ArticleBMC neurology2026
Association of the along‑perivascular space (ALPS) index and white matter volume with cognitive dysfunction in relapsing‑remitting multiple sclerosis patients.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Choroid Plexus MRI Features and Cognitive Outcomes in Multiple Sclerosis: A Scoping Review.Brain sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveTo investigate the relationship among the along perivascular space (ALPS) index, conventional neuroimaging markers, and cognitive impairment in patients with relapsing–remitting multiple sclerosis (RRMS).
methodsThis study included 45 RRMS patients and 41 healthy controls (HC). All participants underwent clinical evaluation, magnetic resonance imaging (MRI), and comprehensive cognitive assessments. Cognitive function was assessed using the Brief International Cognitive Assessment for MS (BICAMS), which includes the Symbol Digit Modalities Test (SDMT), California Verbal Learning Test–II (CVLT-II), and Brief Visuospatial Memory Test–Revised (BVMT-R). Additional tests evaluated attention, executive function, verbal fluency, and global cognition. Cognitive impairment was defined as a Z‑score ≤ -1.5 in at least two of the three BICAMS domains. Spearman correlation and multiple linear regression analyses were used to examine associations between neuroimaging metrics and cognitive scores in RRMS patients. Backward stepwise logistic regression was performed to identify variables independently associated with cognitive impairment.
resultsRRMS patients had a significantly lower ALPS index compared to HC (t = -2.225, q = 0.029). Within the RRMS group, patients with cognitive impairment showed further reductions in the ALPS index. Multiple linear regression confirmed that the ALPS index was significantly associated with Z‑scores of the Symbol Digit Modalities Test (SDMT; β = 0.415, q = 0.003), PASAT-3 s (Paced Auditory Serial Addition Test-3 s; β = 0.305, q = 0.037), PASAT-2 s (β = 0.429, q = 0.002) and Controlled Oral Word Association Test (COWA; β = 0.305, q = 0.044). In addition, a negative correlation was observed between white matter lesion number (WMLN) and the Z‑scores of COWA (β = -0.340, q = 0.013). In the backward stepwise logistic regression model, the ALPS index (OR = 0.044, 95% CI: 0.003–0.776, q = 0.033) and normalized white matter volume (nWMV; OR = 0.764, 95% CI: 0.599–0.975, q = 0.030) were retained as variables independently associated with cognitive impairment.
conclusionOur study suggests that both a reduced ALPS index and lower nWMV are independently associated with cognitive impairment in RRMS. These findings implicate the combined roles of impaired interstitial fluid clearance and structural integrity in RRMS-related cognitive dysfunction. As a non-invasive MR metric, the ALPS index may serve as a potential complementary biomarker for assessing cognitive risk in RRMS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.